MicroRNA circuits regulate the cancer-inflammation link.

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Genetic and epigenetic changes drive cancer development.
• Chronic inflammation is linked to oncogenesis, but the underlying molecular mechanisms remain unclear.
• Inflammatory signaling pathways are frequently activated in various cancers.

Purpose of the Study:

• To identify molecular circuits that sustain inflammatory factor activation in cancer.
• To investigate the role of microRNAs in inflammation-driven oncogenesis.
• To explore the epigenetic regulation of inflammatory circuits in breast cancer.

Main Methods:

• High-throughput screening to identify signal transducer and activator of transcription 3 (STAT3)-regulated microRNAs.
• Analysis of DNA methylation in microRNA promoter regions.
• Overexpression of microRNA miR-146b in breast cancer cells.

Main Results:

• MicroRNA miR-146b was identified as a direct STAT3 target in mammary epithelial cells.
• DNA methylation suppressed miR-146b expression in cancer cells, indicating epigenetic repression.
• Overexpression of miR-146b inhibited nuclear factor κB (NF-κB)-dependent IL6 expression, reduced STAT3 activation, and decreased cancer cell invasiveness and mesenchymal phenotype.

Conclusions:

• A microRNA-mediated anti-inflammatory circuit involving miR-146b is epigenetically repressed in receptor-negative breast cancers.
• This epigenetic silencing contributes to sustained inflammation and oncogenic transformation.
• Targeting this circuit may offer therapeutic potential for estrogen receptor-negative breast cancers.